TP53 and cancer: When stratified by cancer type, early‐onset Hispanic/Latino patients with colon adenocarcinoma exhibited higher PI3K and TP53 pathway alterations compared to early‐onset non‐Hispanic White patients, with only the TP53 pathway alterations reaching statistical significance (p = 0.03).